The purpose of this article is to provide an outline on the involvement of the ERK pathway in breast cancer, focusing on its predictive and prognostic impact within tumor subtypes (a glossary of the drugs mentioned is given at the end of the article). The gene discussed is MAPK1; the disease is breast cancer.